Pharmaceutical company «Darnitsa»

The company has come a long way from a Soviet enterprise to a modern hi-tech pharmaceutical plant. Over the past decade, Darnitsa modernized all its core and ancillary manufacturing facilities, built a robotic warehouse complex for 10,000 pallet positions, invested over €200 million in production, implemented an automated manufacturing planning system, and obtained a GMP certificate.

Such an approach allowed Darnitsa to take the lead among national pharmaceutical producers and become number one in the sales of prepackaged medications in Ukraine.

Beneficiary: Hlib Zagoriy
Chairman, Executive Board of the Managing Company: Dmytro Shymkiv
CEO: Andriy Obrizan

Annually, Darnitsa produces 4.2 billion pills and capsules; 460 million ampoules; 50 million tubes of semi-solid dosage forms; 40 million vials of drops; 30 million vials of powders for injection; 15 million vials of solutions for infusions.